Biotech Values

[DewDiligence]

TEVA spends $2.3B to bulk up in Mexico:

http://finance.yahoo.com/news/teva-accelerates-emerging-markets-growth-120000962.html

Teva Pharmaceutical Industries Ltd. today announced that it has entered into definitive agreements under which the Company will acquire Representaciones e Investigaciones Médicas, S.A. de C.V. (Rimsa), a leading pharmaceutical manufacturing and distribution company in Mexico, along with a portfolio of products and companies, intellectual property, assets and pharmaceutical patents in Latin America and Europe in a debt-free, cash free set of transactions, for an aggregate of $2.3 billion.

Through this acquisition, Teva will become a leading pharmaceutical company in Mexico, the second largest market in Latin America and one of the top five emerging markets globally.